Recreational Drugs Market Size & Share, by Type (Depressants, Stimulants, Euphoriants, Hallucinogens, Inhalants); Application (Supermarkets, Convenience Store) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 6021
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Recreational Drugs Market size was over USD 321.45 million in 2024 and is projected to reach USD 669 million by 2037, growing at around 5.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of recreational drugs is assessed at USD 336.37 million. The market is expanding due to increased demand for legal recreational drugs worldwide. On the other hand, taxes on recreational drugs benefit the economy by providing significant income. New work opportunities in retail are being created, which is transforming the employment landscape. According to recent research, the cannabis business in Canada employed 1,51,000 people and added USD 44 billion to the GDP between 2018 and 2021.

Consumers are seeking new ways of captivating recreational drugs in the form of inhalation or infusion. These processes leave a long-lasting impact on the consumer in comparison to edible ones. This creates opportunity for manufacturers to evolve their old selling patterns to meet the growing demand for recreational drugs.


Recreational Drugs Market
Get more information on this report: Request Free Sample PDF

Recreational Drugs Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing influence among the young generation to consume recreational drugs - The market is emerging, as a result of its increasing need; particularly amongst young people and adults as these drugs offer a pleasant experience to the consumer which may lead to addiction.

    People are interested in experimenting with the effects; if the drugs make them happy and forget their worries or problems, some may get influenced into trying them. Likewise, many reasons activate the urge among people to try recreational drugs, thus stimulating market growth. As per reports, an evaluated 9.5% of adults, i.e., 3.5 million people aged 17-60, had consumed drugs in 2021. This rose to 22% when considering the age group of 17-25.
  • Therapeutic usage of some recreational drugs - Most recreational drugs are prohibited for the general population, but some are still available for therapeutic purposes. This may involve using them for psychological concerns. For instance, as per research, there is evidence to show that medical cannabis and cannabidiol oil (CBD oil) aid with anxiety.

Challenges

  • Variations in laws - Several countries and states have regulated acts and laws to discontinue the usage of recreational drugs but many acts do not adhere to factors such as clinical trials, manufacturing processes along with involvement of multiple authorities. Moreover, these variations create a sense of complexity in understanding the laws and acts, causing a hindrance in the growth of the recreational drugs market.
  • Lack of acceptance of drugs can lead to decreased recreational drugs requirement.
  • Misuse of recreational drugs raises concerns about public safety.

Recreational Drugs Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

5.8%

Base Year Market Size (2023)

USD 321.45 million

Forecast Year Market Size (2036)

USD 669 million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Recreational Drugs Segmentation

Type (Depressants, Stimulants, Euphoriants, Hallucinogens, Inhalants)

The inhalants segment in the recreational drugs market is expected to secure a share of about 38% by the year 2037. The segment is experiencing growth as a result of its preference among adolescent groups as they are legal, inexpensive, and readily available. They are also more likely to engage in delinquent behavior, depression, suicidal thoughts, and substance abuse. More importantly, inhalants provide a short but long-lasting high, making it easy for them to use. All these factors will cause the market to rise.

Application (Supermarkets, Convenience Store)

The convenience store segment is awaited to gain a notable share during the forecast timeline. Some of the most common forms of recreational drugs include caffeine, alcohol, and nicotine among many others. A sizable population diligently uses these forms, which are also freely accessible increasing the market commercial demand. For instance, the percentage of wine and liquor sales at U.S. convenience stores increased from 1.55 percent in 2019 to 1.97 percent in 2020, according to a report released in 2022.

Our in-depth analysis of the market includes the following segments: 

          Type

  • Depressants
  • Stimulants
  • Euphoriants
  • Hallucinogens
  • Inhalants

          Application

  • Supermarkets
  • Convenience store

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Recreational Drugs Industry - Regional Synopsis

North American Market Forecast

According to recreational drugs market trends, the North American region is considered to have a share of about 39% in the coming years. The market expansion is due to rapid urbanization. By 2050, 90% of the U.S. population growth is planned to live in urban areas. A variety of diseases and deviancies can emerge in an urban environment. These include depression, mental instability, substance abuse, alcoholism, and delinquent behavior as well as family disintegration and detachment. There is compelling evidence that urban residents are significantly more likely to report mental illness, which leads to the use of drugs or alcohol as self-medication.

APAC Market Analysis

The Asia Pacific market will register a share of about 27% by the end of 2037. Recreational drug use has increased substantially in India in recent years, being one of the largest producers of legal opium for the pharmaceutical business.

In addition, cannabis has a high industrial potential in India due to its optimal climatic conditions for production and its wide applications in a variety of industries. Cannabis can be used to make hemp fiber and oil, which have a variety of applications in textiles, food supplements, biodegradable plastics, paper, cosmetics, rope, canvas, biofuels, and paint. Hemp is a cannabis plant with minimal THC (less than 0.4%) and high CBD. Hemp farming can also help the environment by lowering soil erosion, water usage, pesticide use, and carbon emissions.

Research Nester
Recreational Drugs Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Recreational Drugs Landscape

    •  Manitoba Harvest
      • Company Overview 
      • Business Strategy 
      • Key Product Offerings 
      • Financial Performance 
      • Key Performance Indicators 
      • Risk Analysis 
      • Recent Development 
      • Regional Presence 
      • SWOT Analysis 
    • Tilray, Inc.
    • Aos Products
    • Suyash Ayurveda
    • Isodiol International Inc.
    • ENDOCA
    • North American Hemp & Grain Co
    • India hemp and co
    • Canopy Growth Corporation
    • Cannablithe

In the News

  • Isodiol International Inc. announced the signing of a non-exclusive distribution agreement with SalesBird, LLC, a well-established U.S. and international sales distribution company. This strategic partnership aims to strengthen Isodiol's internal sales operations, increase market penetration to traditional brick-and-mortar and "big box" retailers, and support the company's efforts to operate in a growing online sales environment.
  • Tilray Medical, a division of Tilray Brands and a global leader in medical cannabis has announced a new Tilray-led scientific publication titled Age-related Patterns of Medical Cannabis Use: A Survey of Authorized Patients in Canada.

Author Credits:  Radhika Pawar


  • Report ID: 6021
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of recreational drugs is assessed at USD 336.37 million.

The recreational drugs market size was over USD 321.45 million in 2024 and is projected to reach USD 669 million by 2037, growing at around 5.8% CAGR during the forecast period i.e., between 2025-2037. Meeting the increasing market pull for recreational drugs due to rise in population, acceptance, and exposure will drive the market growth.

North America industry is anticipated to account for largest revenue share of 39% by 2037, driven by rapid urbanization in the region.

The major players in the market include Manitoba Harvest, Tilray, Inc., Aos Products, Suyash Ayurveda, Isodiol International Inc., ENDOCA, North American Hemp & Grain Co, India hemp and co, Canopy Growth Corporation, Cannablithe
Recreational Drugs Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample